DV
Dividend Vision

BIAF — bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc. (BIAF)

Total return is -99.8% over the past 4 years, 206.4 points behind SPY at 106.6%. Its deepest 1-year drawdown was 96.4%.

BIAF is an equity fund that tracks bioAffinity Technologies, Inc., a single-stock holding established in September 2022. The fund provides direct exposure to a healthcare/biotechnology company with no publicly disclosed dividend distribution rate or expense ratio. This structure appeals primarily to investors seeking concentrated exposure to a single company rather than traditional diversified dividend income strategies.

BIAF key facts

Asset type
Stock
Asset class
Equity
Inception date
09/01/2022
Distribution frequency
None
Last close
$0.40
Market cap
$2,727,468
Average volume
508104.0
Beta
-1.05
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.09